August 2026 · 8 min read
Human AB serum is one of those reagents that sits in the catalogue of every life science supplier — but it rarely gets explained properly. When does it actually outperform FBS? When is it essential rather than just an alternative? And when should you keep using FBS?
This guide covers all of it — from the biology of why AB matters, to the specific applications where human serum is the correct choice, to the practicalities of switching.
What is human AB serum — and why type AB?
Human serum is the cell-free, clot-free fraction of whole blood — the liquid that remains after blood has clotted and the clot plus cells have been removed. It contains proteins (albumin, globulins, complement), growth factors, hormones, lipids, and electrolytes — essentially the same functional classes as FBS, but from a human donor.
Type AB refers to the ABO blood group. AB donors lack both anti-A and anti-B antibodies in their serum — making AB serum the universal type that can be used with cells from any ABO blood group donor without triggering non-specific agglutination or complement-mediated lysis. This is why virtually all human serum used in cell culture is type AB: it eliminates the variable of donor-recipient ABO compatibility.
How human AB serum differs from FBS
| Parameter | FBS | Humanes AB-Serum |
|---|---|---|
| Herkunft | Bovine foetal blood | Human adult donors |
| IgG-Gehalt | 50–200 µg/mL bovine IgG | ~8–12 mg/mL human IgG |
| Wachstumsfaktorprofil | Bovine — high IGF-1, variable EGF/FGF | Human — species-matched for human cells |
| Komplementaktivität | Active (bovine complement) | Active (human complement) — HI available |
| Xenogenic proteins | Yes — bovine albumin, globulins | No — human proteins only |
| Chargenübergreifende Konsistenz | Medium — single animal lots vary | Medium-high — pooled donor lots more stable |
| Regulatory (ATMP/GMP) | Requires TSE/BSE documentation | Human-derived, GMP-grade formulations available |
Where human AB serum is the correct choice
1. PBMC and immune cell assays
This is the single most important application for human AB serum. Peripheral blood mononuclear cells (PBMCs) — T cells, B cells, NK cells, monocytes — are exquisitely sensitive to xenogenic proteins and endotoxin. Standard FBS causes two specific problems in PBMC assays:
- Endotoxin-driven monocyte activation: FBS typically contains 1–10 EU/mL endotoxin, which activates monocytes and macrophages via TLR4, triggering non-specific IFN-γ, TNF-α and IL-6 secretion. In ELISpot assays this creates elevated background spot counts that can completely mask antigen-specific T cell responses.
- Bovine protein immunogenicity: In assays measuring antigen-specific T cell responses, bovine albumin and globulins in FBS can stimulate pre-sensitised T cells non-specifically — particularly in donors with prior bovine protein exposure.
Human AB serum HI (heat inactivated at 56°C for 30 minutes) is the standard for ELISpot, proliferation assays, cytokine multiplex, and CAR-T potency testing. It eliminates both problems simultaneously — no xenogenic proteins, complement inactivated to prevent non-specific lysis.
2. Hybridoma culture and monoclonal antibody production
Wait — didn’t we say FBS is needed for hybridoma? Yes — but human AB serum has a specific role here. During the cloning and early expansion phase of hybridoma development, some groups switch from FBS to human AB serum to eliminate bovine IgG contamination earlier in the workflow.
The caveat: human AB serum contains 8–12 mg/mL human IgG — much higher than FBS. For Protein A/G purification of murine mAb, this is equally problematic. Human AB serum is therefore only suitable for hybridoma applications where the downstream purification does not involve Protein A/G chromatography, or where the murine mAb is purified by an IgG-subclass-specific method that distinguishes human from murine antibodies.
3. IVD assay development and calibrator matrices
IVD (in vitro diagnostics) manufacturers developing immunoassays for clinical markers (troponin, CRP, thyroid hormones, vitamin D, etc.) require a human matrix that closely mimics the patient sample. Human AB serum is the standard reference matrix for:
- Calibrator and control material preparation
- Matrix interference studies (CLSI EP7 protocol)
- Hook effect characterisation
- Cross-reactivity testing
- Lot-to-lot consistency studies for IVD regulatory submissions (EU IVDR 2017/746)
For IVD applications, pooled mixed-donor human AB serum gives more representative inter-individual variation than single-donor material. SeamlessBio supplies pooled human AB serum from EU and US donors with full donor screening documentation required for IVD regulatory submissions.
4. Plasma stability assays in DMPK
For drug candidates susceptible to hydrolysis (esters, amides, prodrugs, peptides), plasma stability is measured by incubating the compound directly in human serum at 37°C. Human AB serum is the appropriate matrix — it contains esterases (butyrylcholinesterase, paraoxonase, carboxylesterases) at physiologically representative concentrations. Pooled human AB serum is preferred over single-donor material to reduce inter-individual enzyme activity variability.
5. Cancer cell lines and primary human cells
For established human cancer cell lines (HeLa, A549, MCF-7, HCT116), human AB serum at 10% is often a direct drop-in replacement for FBS — same concentration, same protocol, no adaptation required. The growth factor profile is species-matched for human cells, eliminating the small but measurable growth factor mismatch inherent in using bovine FBS for human cell lines.
For primary human cells — particularly endothelial cells, keratinocytes, and fibroblasts — human AB serum is often superior to FBS, providing higher proliferation rates and better maintenance of cell phenotype due to species-matched growth factor signalling.
Off-the-Clot (OTC) vs. standard human serum — what is the difference?
Two collection methods produce human serum with different growth factor profiles:
- Standard serum (plasma-derived): Blood is collected with anticoagulant; clotting is then induced by adding calcium chloride. The clotting process is controlled and rapid. Platelet degranulation is minimal — resulting in lower PDGF, TGF-β and EGF than OTC serum. More consistent between lots. Preferred for IVD, diagnostic matrices, and applications requiring defined growth factor baseline.
- Off-the-Clot (OTC) serum: Blood allowed to clot naturally at room temperature without anticoagulant. Natural clotting causes full platelet activation and degranulation, releasing intracellular growth factors (PDGF, EGF, TGF-β, FGF). OTC serum has higher growth factor content than standard serum — closer to hPL in its mitogenic activity. Preferred for cell culture applications requiring maximum growth support.
For PBMC assays and immunology: standard human AB serum HI. For cell proliferation and primary cell culture: OTC human serum. For IVD calibrators and diagnostic matrices: standard human AB serum.
Heat inactivation — when is it required?
Human serum contains active complement proteins that can lyse cells — particularly relevant for PBMC assays where lymphocytes and monocytes are sensitive to complement-mediated lysis. Heat inactivation at 56°C for 30 minutes destroys complement activity (C3, C4, C5 are denatured) without significantly affecting growth factor content or albumin function.
Use HI human serum for: PBMC assays, ELISpot, T cell proliferation, NK cell cytotoxicity assays, any assay where complement-mediated lysis of target cells would confound the readout.
Use non-HI human serum for: IVD calibrators and controls (complement content is part of the physiological matrix being mimicked), protein binding assays, plasma stability assays.
Direct switch from FBS to human AB serum — protocol
For established human cancer cell lines, the switch is usually direct:
- Replace FBS medium with the same basal medium + 10% human AB serum
- Monitor for 2–3 passages: viability, doubling time, morphology
- If parameters hold → no further adaptation needed
For sensitive cell lines or primary cells, use a two-step transition over 4 passages: 50% FBS / 50% human AB serum for 2 passages, then 100% human AB serum.
Note: human AB serum contains significantly more IgG than FBS. If your assay uses anti-human IgG secondary antibodies for detection, validate that the high human IgG background does not create interference — adjust secondary antibody concentration or use Fab fragment-based detection.
Available from SeamlessBio
- Human AB Serum — Mixed Donors: EU and US origin, pooled, standard and heat inactivated. 100 mL and 500 mL.
- Human AB Serum Male: Male-only donor pool for testosterone, PSA and sex-hormone assay development.
- Human OTC Serum: Off-the-clot for maximum growth factor content.
- Custom specifications on request: gamma irradiated, delipidated, IgG-depleted, specific donor age ranges, disease-state sera.
Lot reservation available — essential for IVD assay programmes spanning 6–18 months. Contact us at info@seamlessbio.de for test volumes and quotes within 48 hours.
Summary — five situations where human AB serum is the right call
- PBMC and immune cell assays: ELISpot, cytokine multiplex, T cell proliferation — always human AB serum HI
- IVD calibrator and diagnostic matrix: human matrix required for patient-sample mimicry
- Plasma stability in DMPK: human AB serum gives species-relevant esterase activity
- Primary human cell culture: species-matched growth factors, no xenogenic proteins
- Any assay where bovine IgG or proteins would interfere: flow cytometry with anti-bovine antibodies, assays using human Fc receptor-bearing cells
Further reading on seamlessbio.de:
- Warum Ihr FBS nicht das Problem ist – und womit Sie es ersetzen sollten
- Human Platelet Lysate (hPL) — Complete Guide
- In Vitro Drug Metabolism — CYP450, Microsomes & Hepatocytes
- Hybridoma & mAb Production — FBS & Serum Guide
- Human AB Serum — Full Portfolio
Questions about human serum grade, lot selection or custom specifications? Contact us at info@seamlessbio.de oder request test volumes.
English 
Deutsch